Do you want to read an article? Please log in or register.
GLP-1 receptor agonist-SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes
Further Publications
COMMENTED
Related content
Further Publications
Efficacy of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists in managing MALFD: a meta-analysis of randomized controlled trials
BMC Gastroenterol
Tamilwanan S, Aziz Z, Rong LY, Bitar AN, Zarzour RHA, Alshehade SA
doi: 10.1186/s12876-025-04358-0
Gallbladder and Biliary DiseasesPancreas Diseases
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ann Intern Med
Crisafulli S, Alkabbani W, Paik JM, Bykov K, Tavakkoli A, Glynn RJ, Htoo PT, Yu EW, Trifirò G, Wexler DJ, Patorno E
doi: 10.7326/ANNALS-25-01724
Hepatology
Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLD
J Hepatol
Dukewich M, Wilson LA, Dodge JL, Yuan L, Hameed B, Yates KP, Loomba R, Neuschwander-Tetri BA, Mack W, Terrault N, NASH Clinical Research Network
doi: 10.1016/j.jhep.2026.02.002
Inflammatory Bowel Disease
Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis
Inflamm Bowel Dis
Desai A, Habib H, Khataniar H, Farraye FA, Sehgal P, Barnes EL, Kochhar GS, Hashash JG
doi: 10.1093/ibd/izaf301
Inflammatory Bowel Disease
Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis
J Crohns Colitis
Bayoumy AB, Clarke LM, Deepak P, Desai A, Sehgal P, Gorelik Y, Bar-Yoseph H, Villumsen M, Mulder CJJ, Stenvers DJ, Tushuizen ME, de Boer NKH
doi: 10.1093/ecco-jcc/jjaf181
Inflammatory Bowel Disease
Glucagon-Like Peptide (GLP-1) Receptor Agonists in Inflammatory Bowel Disease: Mechanisms, Clinical Implications, and Therapeutic Potential
J Crohns Colitis
Colwill M, Povlsen S, Pollok R, Patel K, Goodhand J, Ahmad T, Honap S
doi: 10.1093/ecco-jcc/jjaf167
Hepatology
Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, Targher G, Krag A, Rinella ME, Cammà C, Petta S
doi: 10.1016/S2468-1253(25)00188-8
Further Publications
Clinical Outcomes and Risk Factors for Adverse Events Associated With Endoscopic Ultrasound-Guided Drainage of Postoperative Pancreatic Fluid Collections Following Distal Pancreatectomy
J Gastroenterol Hepatol
Lee HS, Huh G, Lee Y, Cho SH, Lee JM, Song TJ, Seo DW, Oh D
doi: 10.1111/jgh.70267
Hepatology
Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease
J Gastroenterol Hepatol
Hsieh ML, Su TH, Lin YC, Chen YY, Tung CF, Huang LS, Wu CH, Peng YC, Hsieh VC
doi: 10.1111/jgh.70259